Bibliography

  1. The metabolomic window into hepatobiliary disease. Beyoğlu D, Idle JR.
    J Hepatol. 2013 Oct;59(4):842-58. doi: 10.1016/j.jhep.2013.05.030. Epub 2013 May 25.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095886/
  2. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. Anstee QM, Day CP.
    J Hepatol. 2012 Nov;57(5):1097-109. doi: 10.1016/j.jhep.2012.04.041. Epub 2012 May 30.
    http://www.journal-of-hepatology.eu/article/S0168-8278(12)00409-6/fulltext
  3. Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine Mazen Noureddin, José M Mato, and Shelly C Lu
    Exp Biol Med (Maywood). 2015 Jun; 240(6): 809–820.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818965/
  4. Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition Joo Ho Lee, Simonetta Friso, and Sang-Woon Choi,
    Nutrients. 2014 Aug; 6(8): 3303–3325.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145310/
  5. Glutathione and mitochondria Vicent Ribas, Carmen García-Ruiz and José C. Fernández-Checa
    Front Pharmacol. 2014; 5: 151.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079069/
  6. S-adenosyl-L-methionine: its role in the treatment of liver disorders.Lieber CS
    Am J Clin Nutr. 2002 Nov;76(5):1183S-7S.
    http://ajcn.nutrition.org/content/76/5/1183S.long
  7. Reversal of liver cirrhosis: current evidence and expectations Young Kul Jung and Hyung Joon Yim.
    Korean J Intern Med 2017;32:213-228
    https://doi.org/10.3904/kjim.2016.268
    http://kjim.org/upload/kjim-2016-268.pdf
  8. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ.
    J Clin Invest. 1998 Aug 1;102(3):538-49.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC508915/
  9. Is liver fibrosis reversible? Benyon RC, Iredale JP.
    Gut. 2000 Apr;46(4):443-6.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1727904/pdf/v046p00443.pdf
  10. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. Sakaguchi S1, Takahashi S, Sasaki T, Kumagai T, Nagata K.
    Drug Metab Pharmacokinet. 2011;26(1):30-46. Epub 2010 Dec 7.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1727904/pdf/v046p00443.pdf
  11. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. Nagata K, Suzuki H, Sakaguchi S.
    Drug Metabolism and Pharmacokinetics Vol. 26 (29011) No. 1 P 30-46 http://doi.org/10.2133/dmpk.DMPK-10-RV-087
    https://www.jstage.jst.go.jp/article/jts/32/5/32_5_453/_article

What is a Medical Food?

A medical food is a non-drug formula that may contain only ingredients that are found on the FDA's GRAS [ READ MORE ]

HonorHealth IRB Human Clinical Trial

Opening text from the associated page for this topic. This is the lead in text for the topic with a link to This is the lead in text for [ READ MORE ]

HepAssure Medical Food and Chronic Liver Disease

Opening text from the associated page for this topic. This is the lead in text for the [ READ MORE ]

HepAssure Ingredients

Opening text from the associated page for this topic. This is the lead in text for the topic with a link to This is the lead in text for the topic with a link to [ READ MORE ]

An informational website provided by TheLiverLab.Com.